BIOSIMILARS HANDBOOK
BIOSIMILARS HANDBOOK
Biosimilar medicines are increasing patient access to care and reducing drug costs…
But what are biosimilars?
Whether you are a patient, caregiver, medical professional, insurer or policy maker, this handbook is designed to give you a crash course on the basics of biosimilars.
Each of our four expert-developed learning tracks will give you a deeper understanding of biosimilars so you can make more informed decisions.
Select a learning track below to learn more.
American Pharmacists Association (APhA): Biosimilars Basics for Patients
The Biosimilars Council partnered with APhA to design a resource that helps patients understand biosimilars when making health care decisions.
October 25, 2022
2022 Savings Report Shows the Value of Biosimilars for Patients with Cancer
Each year, more biosimilars continue to reach new patients, delivering greater savings to them, taxpayers, and the…
October 9, 2021
Pharmacists Can Help Spur Greater Biosimilar Adoption
As trusted partners for patients, pharmacists have a critical role to play in educating consumers about biosimilar medicines…
October 6, 2021
Biosimilars Reach More Patients in 2022, Yet Challenges Remain
Although biosimilars have made great strides in the last year, there remains much work to be done. This…
601 New Jersey Ave NW, Suite 850, Washington DC 20001
601 New Jersey Ave NW, Suite 850, Washington DC 20001
©2023 Biosimilars Council a division of the Association for Accessible Medicines.
